» Articles » PMID: 6128962

The Surgical Management of Medullary Thyroid Carcinoma

Overview
Journal Ann Surg
Specialty General Surgery
Date 1983 Jan 1
PMID 6128962
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Medullary carcinoma of the thyroid may occur in three patient groups: multiple endocrine neoplasia, type 2b (MEN2b), MEN2a, and sporadic. The prognosis is best in MEN2a and worst in MEN2b. Multicentric disease occurs in approximately 90% of patients in the MEN groups and in 20% of the patients in the sporadic group. The minimal surgical procedure advocated is total thyroidectomy with dissection of the central compartment nodes. When neck dissection is performed, there appears to be no advantage in resecting the internal jugular vein or the sternomastoid muscle. Primary relatives of all patients with medullary carcinoma should be screened by measurement of plasma immunoreactive calcitonin to identify C-cell disease in a generally unsuspecting group/reservoir and because it results in earlier diagnosis, which leads to a less extensive surgical procedure and a higher percentage of patients with a disease-free state.

Citing Articles

Prognosis of radiotherapy in medullary thyroid carcinoma patients without distant metastasis.

Huang S, Zhong J, Zhang Z, Chen R, Li J, Sun J Transl Cancer Res. 2022; 10(11):4714-4726.

PMID: 35116326 PMC: 8798267. DOI: 10.21037/tcr-21-1179.


Risk Factors Associated With Reoperation and Disease-Specific Mortality in Patients With Medullary Thyroid Carcinoma.

Kuo E, Sho S, Li N, Zanocco K, Yeh M, Livhits M JAMA Surg. 2017; 153(1):52-59.

PMID: 28973144 PMC: 5833622. DOI: 10.1001/jamasurg.2017.3555.


Genetic and clinical features of multiple endocrine neoplasia types 1 and 2.

Romei C, Pardi E, Cetani F, Elisei R J Oncol. 2012; 2012:705036.

PMID: 23209466 PMC: 3503399. DOI: 10.1155/2012/705036.


Medullary thyroid cancer: clinico-pathological profile and outcome in a tertiary care center in North India.

Mehrotra P, Mishra A, Mishra S, Agarwal G, Agarwal A, Verma A World J Surg. 2011; 35(6):1273-80.

PMID: 21479684 DOI: 10.1007/s00268-011-1086-7.


Prognostic factors for sporadic medullary thyroid carcinoma.

Gulben K, Berberoglu U, Boyabatli M World J Surg. 2005; 30(1):84-90.

PMID: 16369705 DOI: 10.1007/s00268-005-7949-z.


References
1.
Sizemore G, Go V, Kaplan E, Sanzenbacher L, Holtermuller K, Arnaud C . Relations of calcitonin and gastrin in the Zollinger-Ellison syndrome and medullary carcinoma of the thyroid. N Engl J Med. 1973; 288(13):641-4. DOI: 10.1056/NEJM197303292881301. View

2.
Sizemore G, Go V . Stimulation tests for diagnosis of medullary thyroid carcinoma. Mayo Clin Proc. 1975; 50(2):53-6. View

3.
Norton J, Froome L, Farrell R, Wells Jr S . Multiple endocrine neoplasia type IIb: the most aggressive form of medullary thyroid carcinoma. Surg Clin North Am. 1979; 59(1):109-18. DOI: 10.1016/s0039-6109(16)41737-8. View

4.
HOLYOKE E, Block G, Jensen E, Sizemore G, Heath H, Chu T . Biologic markers in cancer diagnosis and treatment. Curr Probl Cancer. 1981; 6(2):1-68. DOI: 10.1016/s0147-0272(81)80007-4. View

5.
BLOCK M, HORN Jr R, Miller J, Barrett J, Brush B . Familial medullary carcinoma of the thyroid. Ann Surg. 1967; 166(3):403-12. PMC: 1477419. DOI: 10.1097/00000658-196709000-00008. View